Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Stefano Gelibter
Observed names:
Gelibter, Stefano,
S Gelibter,
S. Gelibter
Institution:
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
Observed institutions:
Vita-Salute San Raffaele University,
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda,
IRCCS Ospedale San Raffaele,
IRCCS San Raffaele Roma,
Azienda Socio Sanitaria Territoriale di Pavia
ORCID:
0000-0001-7388-4124
Observed ORCID:
0000-0001-7388-4124
OpenAlex ID:
A5030902473
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2025
·
Simon I Hay
, Kanyin Liane Ong
, et al.
·
The Lancet
·
1,334
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2025
·
Mohsen Naghavi
, Hmwe Hmwe Kyu
, et al.
·
The Lancet
·
914
PDF
The impact of storage on extracellular vesicles: A systematic study
2022
·
Stefano Gelibter
, Giulia Marostica
, et al.
·
Journal of Extracellular Vesicles
·
412
PDF
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023
2025
·
Austin E Schumacher
, Peng Zheng
, et al.
·
The Lancet
·
303
Extracellular Vesicles in Neuroinflammation
2021
·
Giulia Marostica
, Stefano Gelibter
, et al.
·
Frontiers in Cell and Developmental Biology
·
87
PDF
Diagnosing autoimmune encephalitis in a real-world single-centre setting
2019
·
Antonino Giordano
, Raffaella Fazio
, et al.
·
Journal of Neurology
·
43
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis?
2021
·
Stefano Gelibter
, Marco Pisa
, et al.
·
Journal of Neurology
·
33
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis
2024
·
Giacomo Greco
, Mario Risi
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
·
28
Progressive visual function impairment as the predominant symptom of the transition phase to secondary progressive multiple sclerosis: A case report
2018
·
A Giordano
, B Colombo
, et al.
·
Multiple Sclerosis and Related Disorders
·
22
Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis
2021
·
Stefano Gelibter
, Marco Pisa
, et al.
·
Annals of Neurology
·
20
Upper limb motor evoked potentials as outcome measure in progressive multiple sclerosis
2019
·
M. Pisa
, R. Chieffo
, et al.
·
Clinical Neurophysiology
·
20
Do immune checkpoint inhibitors affect the course of multiple sclerosis? A systematic review and meta‐analysis
2024
·
Stefano Gelibter
, Lorenzo Saraceno
, et al.
·
European Journal of Neurology
·
14
PDF
COVID-19 with no antibody response in a multiple sclerosis patient treated with cladribine: Implication for vaccination program?
2021
·
Stefano Gelibter
, Mario Orrico
, et al.
·
Multiple Sclerosis and Related Disorders
·
14
PDF
As time goes by: Treatment challenges in elderly people with multiple sclerosis
2024
·
Stefano Gelibter
, Lorenzo Saraceno
, et al.
·
Journal of Neuroimmunology
·
13
Measuring the composition and availability of human resources for health by sex in 204 countries and territories, 1990–2023, and workforce gaps for universal health coverage: a systematic analysis for the Global Burden of Disease Study 2023
2026
·
Megan Knight
, Kelly Bienhoff
, et al.
·
The Lancet Public Health
·
9
Encephalopathy as a prognostic factor in adults with acute disseminated encephalomyelitis following COVID-19
2022
·
Stefano Gelibter
, Gabriele Bellavia
, et al.
·
Journal of Neurology
·
9
PDF
Corpus callosum infarction: radiological and histological findings
2020
·
Stefano Gelibter
, Angela Genchi
, et al.
·
Journal of Neurology
·
6
Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian family
2018
·
S Gelibter
, B Mazzi
, et al.
·
Multiple Sclerosis and Related Disorders
·
6
Tixagevimab and cilgavimab use in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder during anti-CD20 treatment: A single-center experience
2023
·
Stefano Gelibter
, Fiammetta Pirro
, et al.
·
Journal of Neuroimmunology
·
4
Neuromyelitis optica and myotonic dystrophy type 2: a rare association with diagnostic implications
2020
·
Stefano Gelibter
, Lucia Moiola
, et al.
·
Journal of Neurology
·
4
Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19?
2021
·
Mario Orrico
, Agostino Nozzolillo
, et al.
·
Journal of Neurology
·
3
PDF
Allergy and dimethyl fumarate treatment in a patient with multiple sclerosis
2020
·
Stefano Gelibter
, Mario Orrico
, et al.
·
Journal of the Neurological Sciences
·
3
Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing–Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter Study
2026
·
Gianmarco Abbadessa
, Damiano Marastoni
, et al.
·
CNS Drugs
·
2
Combination therapy with cyclophosphamide, rituximab and corticosteroids in order to arrest a rapidly progressive primary CNS vasculitis: a case report with 40-month follow-up remission
2025
·
Lorenzo Saraceno
, Stefano Gelibter
, et al.
·
Clinical Neurology and Neurosurgery
·
2
Changes in circulating pro-inflammatory lymphocytes and cortical excitability with extended-interval natalizumab dosing in multiple sclerosis
2025
·
Marco Pisa
, Tommaso Croese
, et al.
·
Neurological Sciences
·
1
Show more works
View as search
Works count:
34
Citation count:
3,308
H-index:
13
I10-index:
14
Year
Topic
Type